Effects of SGLT2 inhibition on early diabetic kidney disease: interrogation of renal energetics by functional imaging and single-cell transcriptomics- an ancillary study to the ATTEMPT trial (COMIRB #19-2947)
Details
Age
Adult
Type of Study
Treatment
Locations
Childrens Hospital Colorado
Principal Investigator
Petter Bjornstad, MD
Study ID
Protocol Number: 21-4373
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers